Published in Clin Res Cardiol on October 13, 2008
Early repolarization syndrome: a decade of progress. J Electrocardiol (2013) 1.59
Exercise-induced arterial hypertension - an independent factor for hypertrophy and a ticking clock for cardiac fatigue or atrial fibrillation in athletes? F1000Res (2014) 0.88
Comparison of morphological and functional adaptations of the heart in highly trained triathletes and long-distance runners using cardiac magnetic resonance imaging. Heart Vessels (2012) 0.87
Exhaustive exercise training enhances aerobic capacity in American alligator (Alligator mississippiensis). J Comp Physiol B (2009) 0.87
Myocardial deformational adaptations to different forms of training: a real-time three-dimensional speckle tracking echocardiographic study. Heart Vessels (2014) 0.86
Diagnostic superiority of a combined assessment of the systolic and early diastolic mitral annular velocities by tissue Doppler imaging for the differentiation of restrictive cardiomyopathy from constrictive pericarditis. Clin Res Cardiol (2010) 0.86
Combined cardiological and neurological abnormalities due to filamin A gene mutation. Clin Res Cardiol (2010) 0.86
Tako-Tsubo syndrome: dying of a broken heart? Clin Res Cardiol (2010) 0.85
MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation. Pflugers Arch (2013) 0.85
Importance of three-dimensional geometric analysis in the assessment of the athlete's heart. Am J Cardiol (2013) 0.85
Clinical implications of the echocardiographic assessment of left ventricular long axis function. Clin Res Cardiol (2009) 0.83
Benefits and limitations of cardiovascular pre-competition screening in international football. Clin Res Cardiol (2009) 0.80
Echocardiographic measurements of the right ventricle: right ventricular outflow tract 1. Clin Res Cardiol (2010) 0.78
Correlation between ECG abnormalities and cardiac parameters in highly trained asymptomatic male endurance athletes: evaluation using cardiac magnetic resonance imaging. Int J Cardiovasc Imaging (2012) 0.77
Molecular Mechanisms Underlying Cardiac Adaptation to Exercise. Cell Metab (2017) 0.76
Influence of Physical Activity on Hypertension and Cardiac Structure and Function. Curr Hypertens Rep (2015) 0.75
Hypertrophic Cardiomyopathy in a Young Adult with RV Aneurysm: Report of a Rare Finding and Review of the Literature. Heart Views (2011) 0.75
Pitfalls in the differentiation between athlete's heart and hypertrophic cardiomyopathy. Clin Res Cardiol (2009) 0.75
Re: Athlete's heart or hypertrophic cardiomyopathy? Clin Res Cardiol (2009) 0.75
Effects of High-Intensity Training of Professional Runners on Myocardial Hypertrophy and Subclinical Atherosclerosis. PLoS One (2016) 0.75
Heart and athlete. J Tehran Heart Cent (2010) 0.75
Sudden cardiac death in young athletes. Open Access J Sports Med (2011) 0.75
Left ventricular remodeling and the athlete's heart, irrespective of quality load training. Cardiovasc Ultrasound (2016) 0.75
Screening of sarcomere gene mutations in young athletes with abnormal findings in electrocardiography: identification of a MYH7 mutation and MYBPC3 mutations. J Hum Genet (2015) 0.75
Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation (1995) 6.55
The athlete's heart. A meta-analysis of cardiac structure and function. Circulation (2000) 4.04
Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation (2006) 3.82
Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol (2003) 3.52
Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J (2006) 3.22
Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation (1979) 2.68
Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy. Circulation (1969) 2.56
Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol (1981) 2.37
Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis (1985) 2.21
Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol (1986) 2.18
Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med (1999) 2.05
Athlete's heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol (2002) 1.82
Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol (1986) 1.70
Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol (2006) 1.66
Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation (1981) 1.66
Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc (2005) 1.65
Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis. Br Heart J (1980) 1.44
Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation (1995) 1.39
Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. J Am Coll Cardiol (2000) 1.27
Physiological left ventricular hypertrophy or hypertrophic cardiomyopathy in an elite adolescent athlete: role of detraining in resolving the clinical dilemma. Br J Sports Med (2006) 1.06
Coronary risk factors and incidence of coronary death in relation to physical fitness. Seven-year follow-up study of middle-aged and elderly men. Eur Heart J (1985) 0.93
Physical activity, physical fitness, and sudden cardiac death. Epidemiol Rev (1992) 0.91
Exercise-induced cardiac hypertrophy: a substrate for sudden death in athletes? Exp Physiol (2003) 0.90
Risk of competitive sport in young athletes with heart disease. Heart (2003) 0.85
Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy. Heart (2001) 0.84
Comparison of diastolic septal perforator flow velocities in hypertrophic cardiomyopathy versus hypertensive left ventricular hypertrophy. Am J Cardiol (2005) 0.84
Sudden cardiac death and the 'athlete's heart'. Arch Intern Med (1995) 0.83
Physical training, vegetative regulation, and cardiac hypertrophy. J Cardiovasc Pharmacol (1987) 0.83
[Endurance training and cardial adaptation (athlete's heart)]. Herz (2004) 0.82
Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes. Br J Sports Med (2006) 0.81
Left ventricular wall motion during diastolic filling in endurance-trained athletes. Med Sci Sports Exerc (2001) 0.78
The echocardiographic determination of volume and muscle mass of the heart. Int J Sports Med (1996) 0.77
[Sudden death during mass running events in Switzerland 1978-1987: an epidemiologico-pathologic study]. Schweiz Med Wochenschr (1989) 0.77
Sudden death due to physical exercise in the elderly. Coll Antropol (2002) 0.75
[Left ventricular mass in endurance-athletes with athlete's heart and untrained subjects--comparison between different echocardiographic methods and MRI]. Z Kardiol (2003) 0.75
[Hypertrophic cardiomyopathy]. Herz (2005) 0.75
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2007) 6.34
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2013) 3.50
Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor. Clin Chem (2004) 2.23
Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy. Eur Heart J (2005) 2.11
Incidence rates and predictors of major and minor depression in patients with heart failure. Int J Cardiol (2012) 2.05
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation (2004) 1.73
Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure. Eur J Heart Fail (2011) 1.70
A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J (2011) 1.67
Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy. Eur J Heart Fail (2011) 1.63
Method for aortic wall strain measurement with three-dimensional ultrasound speckle tracking and fitted finite element analysis. Ann Thorac Surg (2013) 1.56
Heart rate variability in patients with cardiac hypertrophy--relation to left ventricular mass and etiology. Am Heart J (2006) 1.55
Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. J Am Coll Cardiol (2002) 1.53
Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation (2003) 1.47
Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab (2003) 1.46
Isolated cardiac sarcoidosis associated with the expression of a splice variant coding for a truncated BTNL2 protein. Cardiology (2007) 1.42
Non-compaction cardiomyopathy in an adult with hereditary spherocytosis. Eur J Heart Fail (2006) 1.41
2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases. Rev Esp Cardiol (Engl Ed) (2015) 1.39
Genetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathy. PLoS Genet (2010) 1.37
Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis. J Clin Endocrinol Metab (2004) 1.35
Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy. Basic Res Cardiol (2008) 1.12
Magnetic resonance imaging in pericardial diseases. Indications and diagnostic value. Herz (2006) 1.11
Bacterial pericarditis: diagnosis and management. Am J Cardiovasc Drugs (2005) 1.10
Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery. Chest (2005) 1.09
Osteoprotegerin gene polymorphisms in men with coronary artery disease. J Clin Endocrinol Metab (2004) 1.02
Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol (2003) 0.99
Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction. Clin Res Cardiol (2011) 0.98
Detection of Porphyromonas gingivalis DNA in aortic tissue by PCR. J Periodontol (2002) 0.98
Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol (2006) 0.97
Management strategies in pericardial emergencies. Herz (2006) 0.96
Activated nuclear transcription factor kappaB in patients with myocarditis and dilated cardiomyopathy--relation to inflammation and cardiac function. Biochem Biophys Res Commun (2005) 0.96
Right ventricular cardiac myxoma. Diagnostic usefulness of cardiac magnetic resonance imaging. Herz (2005) 0.95
A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. Mol Genet Metab (2008) 0.95
The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Herz (2002) 0.94
Pericardial syndromes: an update after the ESC guidelines 2004. Heart Fail Rev (2013) 0.93
Economic burden of patients with various etiologies of chronic systolic heart failure analyzed by resource use and costs. Int J Cardiol (2012) 0.93
Parvovirus B19 genome in endomyocardial biopsy specimen. Circulation (2004) 0.93
A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur Heart J (2013) 0.92
Novel point mutations in the mitochondrial DNA detected in patients with dilated cardiomyopathy by screening the whole mitochondrial genome. Biochem Biophys Res Commun (2004) 0.91
Periodontal microbiota in patients with coronary artery disease measured by real-time polymerase chain reaction: a case-control study. J Periodontol (2007) 0.90
Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult. Hum Pathol (2003) 0.90
[2015 ESC Guidelines for the diagnosis and management of pericardial diseases]. Kardiol Pol (2015) 0.89
Sudden cardiac death in dilated cardiomyopathy -- therapeutic options. Herz (2002) 0.89
Increased end diastolic wall stress precedes left ventricular hypertrophy in dilative heart failure--use of the volume-based wall stress index. Int J Cardiol (2011) 0.89
Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy. Pacing Clin Electrophysiol (2006) 0.89
A network against failing hearts--introducing the German "Competence Network Heart Failure". Int J Cardiol (2009) 0.88
Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy. Eur J Hum Genet (2012) 0.88
Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis. Heart Fail Rev (2013) 0.88
Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis. Cardiovasc Pathol (2007) 0.88
Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Electrophysiol (2003) 0.87
Mechanisms involved in the differential reduction of omega-3 and omega-6 highly unsaturated fatty acids by structural heart disease resulting in "HUFA deficiency". Can J Physiol Pharmacol (2011) 0.87
Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependent. J Cell Biochem (2007) 0.86
Recurrent pericarditis: mysterious or not so mysterious? Eur Heart J (2005) 0.86
N-3 polyunsaturated fatty acids and statins in heart failure. Lancet (2009) 0.86
Glycosylphosphatidylinositol-induced cardiac myocyte death might contribute to the fatal outcome of Plasmodium falciparum malaria. Apoptosis (2008) 0.86
Molecular mechanisms involved in atherosclerosis. Herz (2002) 0.86
Endomyocardial fibrosis in Churg-Strauss syndrome assessed by cardiac magnetic resonance imaging. Int J Cardiol (2006) 0.86
Usefulness of cytokines interleukin-6 and interleukin-2R concentrations in diagnosing active infective endocarditis involving native valves. Am J Cardiol (2002) 0.86
[On guidelines for the treatment management]. Herz (2006) 0.85
Diagnostic value of biochemical biomarkers in malignant and non-malignant pericardial effusion. Heart Fail Rev (2013) 0.85
[Guidelines -- substitute textbook guidelines for daily or limited use?]. Herz (2009) 0.85
Genotype-specific effects on left ventricular function in parvovirus B19-positive patients with dilated cardiomyopathy. J Med Virol (2011) 0.85
Prevalence and natural history of heart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study. Eur J Med Res (2007) 0.85
Cytokines in pericardial effusion of patients with inflammatory pericardial disease. Mediators Inflamm (2012) 0.85
[Differentiation of malignant from nonmalignant, inflammatory pericardial effusions with biomarkers]. Herz (2009) 0.84
Long runs of non-sustained ventricular tachycardia on 24-hour ambulatory electrocardiogram predict major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol (2005) 0.84
Biomarkers in inflammatory and noninflammatory cardiomyopathy. Herz (2009) 0.83
The 103I variant of the melanocortin 4 receptor is associated with low serum triglyceride levels. J Clin Endocrinol Metab (2005) 0.83
Inflammation in dilated cardiomyopathy. Herz (2004) 0.83
Diagnosis and treatment of myocarditis: the role of endomyocardial biopsy. Curr Treat Options Cardiovasc Med (2007) 0.82
Genetics of human hypertension. Herz (2003) 0.82
Pathophysiology of cardiac inflammation: molecular mechanisms. Herz (2002) 0.82
Management of pericardial effusion the role of echocardiography in establishing the indications and the selection of the approach for drainage. Herz (2005) 0.81
Lipids and lipoproteins in women. Herz (2005) 0.81
[Excessive hyperchylomicronemia--a rare cause of acute retrosternal and epigastric pain in pregnancy]. Herz (2003) 0.81
Plasmodium falciparum glycosylphosphatidylinositol induces limited apoptosis in liver and spleen mouse tissue. Apoptosis (2007) 0.81
Heart rate turbulence following ventricular premature beats in healthy controls. Ann Noninvasive Electrocardiol (2003) 0.81
Evaluation of the presence of selected viral and bacterial nucleic acids in pericardial samples from dogs with or without idiopathic pericardial effusion. Vet J (2007) 0.81
Detection of anti-hsp70 immunoglobulin G antibodies indicates better outcome in coronary artery bypass grafting patients suffering from severe preoperative angina. Ann Thorac Surg (2004) 0.80
A new but frequent mutation of apoB-100-apoB His3543Tyr. Atherosclerosis (2004) 0.80
Cardiac sarcoidosis: cytokine patterns in the course of the disease. Arch Pathol Lab Med (2003) 0.80
Evidence for CTLA4 as a susceptibility gene for dilated cardiomyopathy. Eur J Hum Genet (2010) 0.80
Association of hyperhomocysteinemia with left ventricular dilatation and mass in human heart. Clin Chem Lab Med (2010) 0.80
Echocardiographic findings mimicking type A aortic dissection. Herz (2006) 0.80
Adverse effects of permanent atrial fibrillation on heart failure in patients with preserved left ventricular function and chronic right apical pacing for complete heart block. Clin Res Cardiol (2012) 0.79
The Biomaterialbank of the German Competence Network of Heart Failure (CNHF) is a valuable resource for biomedical and genetic research. Int J Cardiol (2008) 0.79
Molecular basis of obesity and the risk for cardiovascular disease. Herz (2006) 0.79
Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions. Clin Biochem (2011) 0.79
Viral genomes in the pericardial fluid and in peri- and epicardial biopsies from a German cohort of patients with large to moderate pericardial effusions. Heart Fail Rev (2013) 0.79
Fatty acid oxidation inhibition with PPARalpha activation (FOXIB/PPARalpha) for normalizing gene expression in heart failure? Cardiovasc Res (2005) 0.78
Acute severe thrombocytopenia after c7E3 Fab (abciximab) therapy in a patient with unstable angina and stenting of the right coronary artery. Occurrence of subacute stent thrombosis and safe readministration of the GPIIb/IIIa inhibitor tirofiban. Int J Cardiovasc Intervent (2000) 0.78
Gene expression profiling from endomyocardial biopsy tissue allows distinction between subentities of dilated cardiomyopathy. J Thorac Cardiovasc Surg (2008) 0.78
Trypomastigotes and amastigotes of Trypanosoma cruzi induce apoptosis and STAT3 activation in cardiomyocytes in vitro. Apoptosis (2013) 0.78